GRGRX
Price
$49.14
Change
+$0.38 (+0.78%)
Updated
Sep 4 closing price
Net Assets
414.07M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GRGRX vs VVIAX

Header iconGRGRX vs VVIAX Comparison
Open Charts GRGRX vs VVIAXBanner chart's image
Goldman Sachs Equity Income R
Price$49.14
Change+$0.38 (+0.78%)
VolumeN/A
Net Assets414.07M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GRGRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GRGRX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRGRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GRGRX (414M). VVIAX pays higher dividends than GRGRX: VVIAX (2.10) vs GRGRX (0.99). GRGRX was incepted earlier than VVIAX: GRGRX (18 years) vs VVIAX (25 years). GRGRX (1.45) is less costly to investors than VVIAX (0.05). GRGRX is a more actively managed with annual turnover of: 31.00 vs. VVIAX (9.00). GRGRX has a lower initial minimum investment than VVIAX: GRGRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GRGRX (2.58). VVIAX return over 5 years is better than : 70.16 vs. GRGRX (38.48).
GRGRXVVIAXGRGRX / VVIAX
Total Expense Ratio1.250.052,500%
Annual Report Gross Expense Ratio1.450.052,900%
Fund Existence18 years25 years-
Gain YTD8.5077.850108%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets414M203B0%
Annual Yield % from dividends0.992.1047%
Returns for 1 year2.587.7433%
Returns for 3 years22.9036.6163%
Returns for 5 years38.4870.1655%
Returns for 10 years83.29131.6163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPT111.361.02
+0.92%
Camden Property Trust
NNNN47.850.21
+0.44%
Anbio Biotechnology
TMCI7.17N/A
N/A
Treace Medical Concepts
ISRL12.50-0.06
-0.46%
Israel Acquisitions Corp
CNET1.51-0.06
-3.81%
ZW Data Action Technologies Inc